Cellular and Molecular Biology
Open Access

Cell signalling pathways; MAPK/ERK pathway; PI3K/AKT pathway; Wnt pathway, Notch pathway; JAK/STAT pathway; TGF-β pathway; Emerging pathways; Therapeutic targets

Introduction

Cell signalling pathways are essential for maintaining cellular homeostasis and orchestrating complex biological processes. These pathways involve a series of molecular events that transmit signals from the cell surface to the nucleus, ultimately influencing gene expression and cellular behavior. The study of cell signalling has provided insights into the mechanisms underlying cellular responses to environmental changes, development, and disease. Understanding these pathways is crucial for identifying therapeutic targets and developing interventions for various diseases, including cancer, cardiovascular disorders, and neurodegenerative diseases. The MAPK/ERK (Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase) pathway is a key signalling cascade involved in regulating cell growth, differentiation, and survival. It is activated by various growth factors and mitogens, leading to a series of phosphorylation events that ultimately activate ERK proteins. Activated ERK translocates to the nucleus, where it regulates the expression of genes involved in cell proliferation and differentiation. Dysregulation of the MAPK/ERK pathway is associated with various cancers and developmental disorders, making it a prominent target for therapeutic intervention [1].

The PI3K/AKT (Phosphoinositide 3-Kinase/Protein Kinase B) pathway is crucial for regulating cell metabolism, growth, and survival. Activation of PI3K leads to the production of phosphatidylinositol (3,4,5)-trisphosphate (PIP3), which recruits and activates AKT. Activated AKT then phosphorylates a range of substrates involved in promoting cell survival and growth. The PI3K/AKT pathway is frequently dysregulated in cancer, leading to uncontrolled cell proliferation and resistance to apoptosis. Targeting this pathway has shown promise in cancer therapy and other diseases. The Wnt signalling pathway plays a critical role in cell fate determination, tissue homeostasis, and stem cell maintenance. The pathway is activated by Wnt proteins binding to Frizzled receptors, leading to the inhibition of glycogen synthase kinase 3β (GSK-3β) and stabilization of β-catenin. Stabilized β-catenin translocates to the nucleus, where it regulates the expression of genes involved in cell proliferation and differentiation. Aberrant Wnt signalling is implicated in various diseases, including cancer, where it can drive tumorigenesis and affect cellular behavior [2].

The Notch signalling pathway is essential for cell differentiation, development, and tissue homeostasis. Activation of Notch receptors by their ligands leads to the cleavage of the Notch intracellular domain (NICD), which translocates to the nucleus and regulates target gene expression. Notch signalling influences various developmental processes, including neurogenesis and hematopoiesis. Dysregulation of Notch signalling can result in developmental disorders and malignancies, making it an important area of research for understanding disease mechanisms and developing therapeutic strategies. The JAK/STAT (Janus Kinase/Signal Transducer and Activator of Transcription) pathway is a key regulator of immune responses, hematopoiesis, and cell growth. Cytokines and growth factors activate receptors that are associated with JAKs, leading to their phosphorylation and activation. Activated JAKs then phosphorylate STAT proteins, which translocate to the nucleus and regulate gene expression. The JAK/STAT pathway is involved in various diseases, including autoimmune disorders and cancers, and targeting this pathway has therapeutic potential [3].

Cell signalling pathways are fundamental to the complex orchestration of cellular processes that maintain homeostasis, regulate development, and respond to environmental stimuli. These pathways involve a series of molecular interactions that transmit signals from the cell surface to the nucleus, orchestrating a wide range of cellular activities such as proliferation, differentiation, metabolism, and apoptosis. Through these signalling cascades, cells can communicate with their environment, adapt to changes, and ensure proper functioning and survival.

The concept of cell signalling has evolved significantly since its early discoveries, revealing a sophisticated network of intracellular and extracellular interactions. At the core of these pathways are signal transduction mechanisms, which convert extracellular signals into specific cellular responses. These mechanisms often involve receptors on the cell surface that, upon binding to their ligands, activate intracellular signalling proteins. These proteins then relay the signal through a cascade of phosphorylation and dephosphorylation events, ultimately leading to changes in gene expression and cellular behavior [4].

Several key signalling pathways have been extensively studied due to their critical roles in various physiological processes and diseases. The MAPK/ERK pathway, for example, is central to regulating cell growth and differentiation, while the PI3K/AKT pathway is crucial for controlling cell metabolism and survival. The Wnt signalling pathway plays a significant role in development and tissue homeostasis, and the Notch pathway is important for cell fate determination and differentiation. Each of these pathways has been linked to numerous health conditions, including cancer, cardiovascular diseases, and neurodegenerative disorders [5].

The study of cell signalling pathways has provided profound insights into the mechanisms underlying cellular function and disease. Advances in molecular biology and high-throughput technologies have enabled researchers to uncover the intricate details of these pathways, leading to a better understanding of their roles in health and disease. This knowledge has paved the way for the development of targeted therapies that aim to correct signalling abnormalities associated with various conditions.

In this review, we will explore the major cell signalling pathways, their mechanisms of action, and their implications for health and disease. We will examine the MAPK/ERK, PI3K/AKT, and Wnt pathways in detail, as well as discuss emerging pathways and recent advancements in the field. By highlighting the significance of these pathways and the challenges associated with their study, we aim to provide a comprehensive overview of the current state of cell signalling research and its potential for advancing medical science and therapeutic interventions [6].

Discussion

Cell signalling pathways are central to understanding how cells communicate with their environment and regulate their internal processes. These pathways, through a cascade of molecular interactions, orchestrate essential cellular functions including growth, differentiation, metabolism, and apoptosis. The complexity of these pathways reflects their crucial roles in maintaining cellular homeostasis and responding to external stimuli. This discussion highlights the significance of key signalling pathways, their implications for health and disease, and the challenges and future directions in the field [7].

Cell signalling pathways are integral to understanding the mechanisms that govern cellular processes and their deviations in disease states. The MAPK/ERK pathway, PI3K/AKT pathway, and Wnt pathway are central to many cellular functions, and their dysregulation is frequently linked to various diseases, including cancer, cardiovascular disorders, and neurodegenerative diseases. The MAPK/ERK pathway, which mediates responses to growth factors and regulates cell proliferation and differentiation, is often aberrant in cancers, leading to uncontrolled cell growth and resistance to apoptosis. Targeting this pathway with specific inhibitors offers a promising therapeutic strategy, though challenges such as drug resistance and pathway redundancy remain [8].

Similarly, the PI3K/AKT pathway, critical for cell survival and metabolism, is often hyperactivated in cancer, highlighting the potential of PI3K/AKT inhibitors in therapeutic development. However, the complexity and overlap of signalling pathways necessitate precise targeting to avoid off-target effects and optimize therapeutic efficacy. The Wnt pathway, crucial for developmental processes and tissue homeostasis, is implicated in a variety of cancers and developmental disorders. Research into Wnt pathway modulators is ongoing, with the aim of developing targeted therapies that can correct aberrant signalling without disrupting normal cellular functions [9].

Beyond these well-characterized pathways, emerging pathways like the Hippo and mTOR pathways are revealing new insights into cellular regulation and disease mechanisms. The dynamic nature of signalling pathways and their context-dependent effects present both opportunities and challenges for therapeutic development. Future research will benefit from integrating multi-omics approaches to capture the complexity of signalling networks and their interactions. Personalized medicine approaches, guided by individual signalling profiles, hold promise for improving treatment outcomes and minimizing adverse effects. Overall, continued advances in cell signalling research are crucial for unraveling the intricate mechanisms of cellular function and developing innovative therapies for a range of diseases [10].

Conclusion

Cell signalling pathways are fundamental to the regulation of cellular processes and the maintenance of homeostasis. Understanding these pathways provides valuable insights into normal cellular function and the mechanisms underlying various diseases. As research advances, new technologies and discoveries will continue to enhance our knowledge of cell signalling and its applications in medicine. Targeting specific signalling pathways holds promise for developing novel therapeutic strategies and improving patient outcomes across a range of diseases.

Acknowledgement

None

Conflict of Interest

None

References

1. Varghese S, Aggarwal A (2011) Extended spectrum beta-lactamase production in Shigella isolates-A matter of concern. Indian J Med Microbiol 29: 76.

Google Scholar, Crossref, Indexed at

2. Peirano G, Agersø Y, Aarestrup FM, Dos Prazeres Rodrigues D (2005) Occurrence of integrons and resistance genes among sulphonamide-resistant Shigella spp. from Brazil. J Antimicrob Chemother 55: 301–305.

Google Scholar, Crossref, Indexed at

3. Kang HY, Jeong YS, Oh JY, Tae SH, Choi CH, et al. (2005) Characterization of antimicrobial resistance and class 1 integrons found in Escherichia coli isolates from humans and animals in Korea. J Antimicrob Chemother 55: 639-644.

Google Scholar, Crossref, Indexed at

4. Pan J-C, Ye R, Meng D-M, Zhang W, Wang H-Q, et al. (2006) Molecular characteristics of class 1 and class 2 integrons and their relationships to antibiotic resistance in clinical isolates of Shigella sonnei and Shigella flexneri. J Antimicrob Chemother 58: 288–296.

Google Scholar, Crossref, Indexed at

5. The HC, Thanh DP, Holt KE, Thomson NR, Baker S (2016) The genomic signatures of Shigella evolution, adaptation and geographical spread. Nat Rev Microbiol 14: 235.

Google Scholar, Crossref, Indexed at

6. Gupta A, Polyak CS, Bishop RD, Sobel J, Mintz ED (2004) Laboratory-confirmed shigellosis in the United States, 1989- 2002:  Epidemiologic trends and patterns. Clin Infect Dis 38: 1372-1377.

Google Scholar, Crossref, Indexed at

7. Murugesan P, Revathi K, Elayaraja S, Vijayalakshmi S, Balasubramanian T (2012) Distribution of enteric bacteria in the sediments of Parangipettai and Cuddalore coast of India. J Environ Biol 33: 705-11.

Google Scholar, Indexed at

8. Torres AG (2004) Current aspects of Shigella pathogenesis. Rev Latinoam Microbiol 46: 89-97.

Google Scholar, Indexed at

9. Varghese S, Aggarwal A (2011) Extended spectrum beta-lactamase production in Shigella isolates-A matter of concern. Indian J Med Microbiol 29: 76.

Google Scholar, Crossref, Indexed at

10. Peirano G, Agersø Y, Aarestrup FM, Dos Prazeres Rodrigues D (2005) Occurrence of integrons and resistance genes among sulphonamide-resistant Shigella spp. from Brazil. J Antimicrob Chemother 55: 301–305.

Google Scholar, Crossref, Indexed at